PVLA
Palvella Therapeutics Inc

181
Mkt Cap
$1.05B
Volume
435,217.00
52W High
$112.00
52W Low
$11.17
PE Ratio
-7.68
PVLA Fundamentals
Price
$96.81
Prev Close
$88.98
Open
$90.01
50D MA
$83.76
Beta
0.96
Avg. Volume
267,857.84
EPS (Annual)
-$7.83
P/B
27.75
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Palvella Therapeutics (NASDAQ:PVLA) Trading Up 6.6% on Analyst Upgrade
Palvella Therapeutics (NASDAQ:PVLA) Trading 6.6% Higher on Analyst Upgrade...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
TD Cowen Increases Palvella Therapeutics (NASDAQ:PVLA) Price Target to $133.00
TD Cowen lifted their price target on Palvella Therapeutics from $97.00 to $133.00 and gave the company a "buy" rating in a report on Tuesday...
MarketBeat·20h ago
News Placeholder
XTX Topco Ltd Acquires Shares of 17,701 Palvella Therapeutics, Inc. $PVLA
XTX Topco Ltd bought a new stake in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·10d ago
News Placeholder
Palvella Therapeutics (NASDAQ:PVLA) Trading 8% Higher - Still a Buy?
Palvella Therapeutics (NASDAQ:PVLA) Stock Price Up 8% - Here's What Happened...
MarketBeat·11d ago
News Placeholder
Palvella Therapeutics (NASDAQ:PVLA) Stock Price Down 7.9% - Should You Sell?
Palvella Therapeutics (NASDAQ:PVLA) Stock Price Down 7.9% - Here's What Happened...
MarketBeat·15d ago
News Placeholder
Palvella Therapeutics, Inc. (NASDAQ:PVLA) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) have earned an average recommendation of "Buy" from the thirteen brokerages that are currently covering the stock, Marketbeat...
MarketBeat·16d ago
News Placeholder
Palvella Therapeutics, Inc. $PVLA Stake Reduced by Adams Street Partners LLC
Adams Street Partners LLC lowered its stake in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) by 27.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund...
MarketBeat·19d ago
News Placeholder
Palvella Therapeutics (NASDAQ:PVLA) Stock Price Up 7.9% - Should You Buy?
Palvella Therapeutics (NASDAQ:PVLA) Trading Up 7.9% - Time to Buy...
MarketBeat·22d ago
News Placeholder
Insider Selling: Palvella Therapeutics (NASDAQ:PVLA) COO Sells 4,302 Shares of Stock
Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) COO Kathleen Goin sold 4,302 shares of the stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price...
MarketBeat·24d ago
News Placeholder
Kathleen Goin Sells 4,302 Shares of Palvella Therapeutics (NASDAQ:PVLA) Stock
Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) COO Kathleen Goin sold 4,302 shares of the business's stock in a transaction dated Wednesday, November 19th. The stock was sold at an...
MarketBeat·25d ago
<
1
2
...
>

Latest PVLA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.